cerascreen is a digital health start-up, revolutionizing the self-test space by offering a seamless at-home or on-the-go testing experience. Founded in 2012, this Germany-based company operates in key sectors such as Digital Health, Health Care, and Health and Wellness.
With a customer-centric approach, cerascreen provides a variety of self-tests for food intolerances, allergies, and other medical conditions through multiple channels including eCommerce, pharmacies, and health practitioners. Their unique offering includes a personalized online health assessment and analysis that accompanies test results, promising an engaging user experience aimed at maintaining and improving health for their customers.
Though last marking investment through a Seed Round on 01 March 2012, cerascreen has shown potential for growth in the expanding digital health market. Investors should note the absence of listed investors from the last investment, indicating potential opportunities for fresh capital injection as the company scales its innovative offerings in the increasingly health-conscious global market.